Immunotherapy in liver cancer

Immunotherapy for Liver Cancer - American Cancer Society

Ipilimumab can be used in combination with nivolumab to treat liver cancer that has previously been treated (such as with the targeted drug ...

Immunotherapy for Liver Cancer - Cancer Research Institute

Immunotherapy for liver cancer can enhance cancer-fighting immune system responses, but may not always be available or viable for patients with a history of ...

Immunotherapy for Liver Cancer | Moffitt

Immunotherapy for liver cancer most often involves checkpoint inhibitors, which are able to counteract that process by preventing PD-L1 proteins on cancerous ...

Immunotherapy for hepatocellular carcinoma: Current status and ...

Immunotherapy increases survival rates and provides long-term cancer control in subsets of HCC patients while also minimizing side effects. Further research ...

FDA Approves New Immunotherapy Combination To Treat ...

How the New Combination Immunotherapy for Liver Cancer Works ... Both immunotherapy drugs are checkpoint inhibitors — which means they help ...

Immunotherapy and targeted drugs for liver cancer

All of the drugs listed here are for a type of primary liver cancer called hepatocellular carcinoma (HCC).

Immunotherapy for Liver Cancer: How It Works, Success Rates, and ...

Immunotherapy is an emerging treatment option for liver cancer. It involves taking medications that stimulate your immune system to recognize and destroy cancer ...

Expanding Immunotherapy Options for Liver Cancer Patients

As a result of the new approval, pembrolizumab can now be used for treating patients with hepatocellular carcinoma — the most common form of primary liver ...

Combined therapy makes headway for liver cancer

A drug that targets a protein known as phosphatidylserine boosted the response rate for hepatocellular carcinoma (HCC) patients receiving ...

Biomarker May Predict Immunotherapy Response in Liver Cancer

The study, published Oct. 17 in Molecular Cell, provides new insights into a pair of proteins, called p62 and NBR1, and their opposing functions ...

Immunotherapy Before Liver Cancer Surgery Can Kill Tumor, and ...

Results from first-of-its-kind Mount Sinai study show that immunotherapy before liver cancer surgery can kill tumor, and likely residual cancer ...

Immunotherapy for liver cancer: Drugs and possible side effects

Immunotherapy for liver cancer: Drugs and possible side effects ... Immunotherapy helps support the immune system in attacking cancer cells and is ...

Transplantation for Advanced Liver Cancer Patients - Cedars-Sinai

Now a study led by Cedars-Sinai Cancer investigators has concluded that immunotherapy could make liver transplant an option for patients with ...

Researchers offering hope for liver cancer patients

Immunotherapy is the most effective treatment for hepatocellular carcinoma or HCC, a type of liver cancer which can develop when a patient has ...

Advances in immunotherapy for hepatocellular carcinoma - Nature

Hepatocellular carcinoma (HCC) is a prevalent disease with a progression that is modulated by the immune system. Systemic therapy is used in ...

Immunotherapy in liver cancer: overcoming the tolerogenic liver ...

This review aims to dissect the intricacies of the liver's immune environment and explore how current and emerging immunotherapeutic strategies are being ...

Immunotherapy for advanced hepatocellular carcinoma

IMMUNOGENICITY IN HCC. Immunotherapies are potentially promising therapeutic strategies in HCC. A complex interdependent relationship exists between chronic ...

A New Strategy to Transform Liver Cancer Immunotherapy

Liver cancer can be rendered highly responsive to an immune checkpoint inhibitor known as anti-PD-L1 antibody by using a synthetic dsRNA molecule dubbed polyIC.

Cancer vaccine with immunotherapy shrinks liver tumors, trial shows

Researchers say a personalized cancer vaccine with immunotherapy increased tumor shrinkage compared to immunotherapy alone.

The next evolution in expanding access to liver transplantation

In pre-transplant patients, immunotherapy may improve downstaging success and tumour control at the cost of some immunologic risks. These include immune-related ...